- Home
- UBS vs MCK Comparison
UBS vs MCK Comparison
Compare UBS & MCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBS
- MCK
- Stock Information
- Founded
- UBS 1862
- MCK 1833
- Country
- UBS Switzerland
- MCK United States
- Employees
- UBS N/A
- MCK N/A
- Industry
- UBS Major Banks
- MCK Other Pharmaceuticals
- Sector
- UBS Finance
- MCK Health Care
- Exchange
- UBS Nasdaq
- MCK Nasdaq
- Market Cap
- UBS 97.0B
- MCK 88.5B
- IPO Year
- UBS N/A
- MCK N/A
- Fundamental
- Price
- UBS $33.72
- MCK $726.57
- Analyst Decision
- UBS Buy
- MCK Buy
- Analyst Count
- UBS 3
- MCK 11
- Target Price
- UBS N/A
- MCK $702.45
- AVG Volume (30 Days)
- UBS 2.8M
- MCK 738.4K
- Earning Date
- UBS 07-30-2025
- MCK 08-06-2025
- Dividend Yield
- UBS 2.20%
- MCK 0.39%
- EPS Growth
- UBS N/A
- MCK 14.87
- EPS
- UBS 1.51
- MCK 25.72
- Revenue
- UBS $47,760,000,000.00
- MCK $359,051,000,000.00
- Revenue This Year
- UBS $1.11
- MCK $14.20
- Revenue Next Year
- UBS $2.42
- MCK $7.86
- P/E Ratio
- UBS $20.47
- MCK $28.39
- Revenue Growth
- UBS 9.69
- MCK 16.22
- 52 Week Low
- UBS $25.75
- MCK $464.42
- 52 Week High
- UBS $35.84
- MCK $736.36
- Technical
- Relative Strength Index (RSI)
- UBS 58.33
- MCK 56.67
- Support Level
- UBS $30.36
- MCK $708.16
- Resistance Level
- UBS $32.31
- MCK $733.10
- Average True Range (ATR)
- UBS 0.48
- MCK 11.76
- MACD
- UBS -0.02
- MCK -0.49
- Stochastic Oscillator
- UBS 64.52
- MCK 72.52
About UBS UBS Group AG Registered
The core of UBS is its global wealth management business focusing on high and ultra-high-net-worth individuals. UBS is also a conventional retail and commercial bank in its Swiss home market. Its investment bank and asset management businesses support its wealth management operations, but also leverage its strength in wealth management to serve third-party clients.
About MCK McKesson Corporation
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.